Diagnostic Research Program Yields A 98% Success Rate Of Viable Sample Delivery
Source: PRA Health Sciences
A biotechnology company selected PRA’s Clinical Diagnostic Services (CDS) group to conduct a global diagnostic study, which involved validating innovative, non-invasive blood sample test results collected from high-risk pregnant women against the “gold standard” results from amniocentesis or chorionic villus sampling.
To successfully complete the program, the PRA team had to ensure the study tested only high-quality maternal blood samples. Therefore, the study would need to over-enroll for any damaged samples, which would require additional funds.
access the Case Study!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
This website uses cookies to ensure you get the best experience on our website. Learn more